• 

  Covishield vaccine consignments arrive across various cities

  India | January 12, 2021 14:46 IST

  A SpiceJet flight carrying the vaccines left for the national capital around 8 am, three hours after three trucks with the maiden consignment of the vaccines rolled out of the Serum Institute of India facility, 15 km from the airport.

• 

  First Covishield vaccine consignment leaves Serum Institute for 13 locations

  India | January 12, 2021 9:53 IST

  Three temperature-controlled trucks rolled out of the Serum Institute gates shortly before 5 am and left for Pune airport, from where the vaccines will be flown across India.

• 

  Serum Institute receives govt order for 11 million vaccine doses, likely to be dispatched tomorrow

  India | January 11, 2021 17:41 IST

  Pune-based vaccine major Serum Institute of India (SII) on Monday said it has received an order from the government for as many as 11 million vaccine doses of Covishield, ahead of the January 16 mega vaccination drive.

• 

  Did you know face serums can work wonders for your skin? Know how

  Beauty | January 09, 2021 19:09 IST

  Is your skincare routine essentially complete by simply using a cleanser, toner, moisturizer? In order to achieve that smooth and glossy skin one must begin with serums. Serums are the pinnacle of gold captured in a small bottle for the eternal youthful skin.

• 

  DCGI grants permission to Serum Institute to manufacture its COVID-19 vaccine ‘Covishield’

  India | January 04, 2021 11:02 IST

  Drugs Controller General of India grants permission to Serum Institute of India to manufacture its COVID-19 vaccine ‘Covishield’. The Pune-based company earlier stated that ChAdOx1 nCov-2019 coronavirus vaccine, developed by teams at the University of Oxford, has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years of age.

• 

  'Covishield' ready to roll out in coming weeks: Adar Poonawalla

  India | January 03, 2021 12:08 IST

  Poonawalla'' remarks came soon after after India's drugs regulator, Drug Controller General of India (DCGI) approved Covishield for restricted emergency use.

• 

  Vaccine of the BJP, won't take shot, says Akhilesh Yadav; faces flak

  India | January 02, 2021 23:24 IST

  Samajwadi Party president Akhilesh Yadav Saturday termed the COVID-19 vaccines to be rolled out in the country as "vaccine of the BJP" and said he would not take the shot, drawing a sharp retort from the ruling party which accused him of "insulting" the doctors and scientists.

• 

  Covid-19 vaccines: Expert panel to meet today to review data on Serum Institute, Bharat Biotech

  News | January 01, 2021 12:02 IST

  The subject expert committee (SEC) of the national drugs regulator will meet again on Friday to take a decision on the emergency-use authorisation (EUA) application of Serum Institute of India’s (SII) Oxford-AstraZeneca and Bharat Biotech’s vaccine candidates against Coronavirus disease (Covid-19).

• 

  Serum Institute's request for emergency use approval of Covid vaccine to be considered today

  India | December 30, 2020 14:59 IST

  Serum Institute of India's application for emergency use authorisation will be considered by the expert panel today. This development comes hours after the UK government accepted the recommendation from the Medicines and Healthcare Regulatory Agency (MHRA) to authorise Oxford University-AstraZeneca's Covid-19 vaccine, named Covishield, for emergency use.

• 

  'DCGI seeking more data for emergency use authorisation won't impact timeline for vaccine roll-out'

  India | December 15, 2020 22:21 IST

  The applications of Bharat Biotech, Serum Institute and Pfizer seeking emergency use authorisation for their COVID-19 vaccines are being examined, the Centre said on Tuesday asserting that drug regulator DCGI seeking more data from these companies will not impact the vaccine-roll out timeline.  

• 

  Only India can satisfy world's Covid vaccine needs: Foreign envoys after Bharat Biotech tour

  India | December 09, 2020 18:18 IST

  Australian Ambassador to India Barry O'Farrell lauded the country's effort on development of a vaccine against coronavirus saying, "There're many vaccines being produced in countries around the world but there's only one country that has the manufacturing capacity to produce sufficient quantities to satisfy the demands of citizens in every country & that's India."

Advertisement
• 

  Covid vaccine coming soon! Serum Institute seeks emergency use nod for Covishield in India

  News | December 07, 2020 20:42 IST

  Covishield is logistically feasible for distribution in India's both urban and rural parts as it can be stored at two to eight degrees Celsius, which is an ideal temperature for being kept in cold storages in the country.

• 

  Adar Poonawalla of Serum Institute of India among 6 ‘Asians of the Year’ named by Singapore daily

  Business | December 05, 2020 10:17 IST

  Pune-based Serum Institute of India (SII) has collaborated with the University of Oxford and the British-Swedish pharmaceutical company AstraZeneca for making the Covid-19 vaccine, ‘‘Covidshield’‘, and is conducting trials in India.

• 

  Serum Institute rejects charges levelled by vaccine trial participant, seeks ₹100cr damages

  India | November 29, 2020 20:40 IST

  Vaccine major Serum Institute of India on Sunday rejected charges that a COVID-19 vaccine candidate has serious side effects, and threatened to seek heavy damages for "malicious" allegations.

• 

  Haqikat Kya Hai: PM Modi visits Serum Institute to review coronavirus vaccine development

  Hakikat Kya Hai | November 28, 2020 23:21 IST

  After visiting Zydus Cadila's plant in Ahmedabad and Bharat Biotech in Hyderabad, Prime Minister Narendra Modi who is on a day-tour to review coronavirus vaccines development across different hubs in the country has reached Pune in Maharashtra. He will visit Serum Institute of India (SII) which is manufacturing Oxford-AstraZeneca's Covishield vaccine for the contagious disease.